Autoimmune Diseases  >>  Copaxone 3TW (glatiramer acetate three times a week)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Copaxone 3TW (glatiramer acetate three times a week) / Teva
NCT00078338: Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis

Completed
4
764
US, Europe, RoW
Rebif®, Recombinant interferon beta-1a, Copaxone®, Glatiramer acetate
EMD Serono, Pfizer
Relapsing-remitting Multiple Sclerosis
11/06
11/06

Download Options